ES2183801T3 - Composiciones del receptor de acetilcolina nicotinico neuronal humano y procedimientos que lo usan. - Google Patents

Composiciones del receptor de acetilcolina nicotinico neuronal humano y procedimientos que lo usan.

Info

Publication number
ES2183801T3
ES2183801T3 ES91908704T ES91908704T ES2183801T3 ES 2183801 T3 ES2183801 T3 ES 2183801T3 ES 91908704 T ES91908704 T ES 91908704T ES 91908704 T ES91908704 T ES 91908704T ES 2183801 T3 ES2183801 T3 ES 2183801T3
Authority
ES
Spain
Prior art keywords
acetilcoline
procedures
receiver
compositions
neuronal nicotinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91908704T
Other languages
English (en)
Inventor
Michael Miller Harpold
Stephen Bradley Ellis
Paul Brust
Michael Akong
Gonul Velicelebi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2183801T3 publication Critical patent/ES2183801T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBEN SUBUNIDADES DE RECEPTORES DE ACETILCOLINA NICOTINICOS NEURONALES HUMANOS, COMO SE DESCRIBEN METODOS PARA PRODUCIR CELULAS QUE CONTIENEN RECEPTORES FUNCIONALES QUE EMPLEAN TALES SUBUNIDADES. TAMBIEN SE DESCRIBEN METODOS DE ANALISIS PARA DETERMINAR LA PRESENCIA DE RACOHNS EN CELULAS TRANSFECTADAS Y PARA DETERMINAR LA ACTIVIDAD AGONISTA O ANTAGONISTA DE LOS COMPUESTOS RESPECTO A DICHAS CELULAS.
ES91908704T 1990-04-03 1991-04-03 Composiciones del receptor de acetilcolina nicotinico neuronal humano y procedimientos que lo usan. Expired - Lifetime ES2183801T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/504,455 US5369028A (en) 1990-04-03 1990-04-03 DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same

Publications (1)

Publication Number Publication Date
ES2183801T3 true ES2183801T3 (es) 2003-04-01

Family

ID=24006339

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91908704T Expired - Lifetime ES2183801T3 (es) 1990-04-03 1991-04-03 Composiciones del receptor de acetilcolina nicotinico neuronal humano y procedimientos que lo usan.

Country Status (7)

Country Link
US (2) US5369028A (es)
EP (1) EP0523187B1 (es)
AT (1) ATE226247T1 (es)
CA (1) CA2078572C (es)
DE (1) DE69133135T2 (es)
ES (1) ES2183801T3 (es)
WO (1) WO1991015602A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683912A (en) * 1994-07-21 1997-11-04 The Salk Institute For Biological Studies Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit
US6440681B1 (en) 1990-04-03 2002-08-27 Merck & Co., Inc. Methods for identifying agonists and antagonists for human neuronal nicotinic acetylcholine receptors
US5369028A (en) * 1990-04-03 1994-11-29 The Salk Institute Biotechnology/Industrial Associates, Inc. DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same
US5401629A (en) 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
DK0548165T3 (da) 1990-09-13 2001-07-16 Univ Duke Ekspression af G-proteinkoblede receptorer i gær
DE4138621A1 (de) * 1991-11-25 1993-06-17 Boehringer Ingelheim Int Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg
US5670113A (en) * 1991-12-20 1997-09-23 Sibia Neurosciences, Inc. Automated analysis equipment and assay method for detecting cell surface protein and/or cytoplasmic receptor function using same
DE69434067T2 (de) * 1993-03-08 2006-03-02 Merck & Co., Inc. Menschliche neuronale nikotin-acetylcholin-rezeptor-verbindungen und methoden ihres einsatzes
US7235648B1 (en) 1993-03-31 2007-06-26 Cadus Technologies, Inc. Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US6255059B1 (en) 1993-03-31 2001-07-03 Cadus Pharmaceutical Corporation Methods for identifying G protein coupled receptor effectors
US6100042A (en) 1993-03-31 2000-08-08 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
WO1995013299A1 (en) * 1993-11-08 1995-05-18 The Salk Institute Biotechnology/Industrial Associates, Inc. Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
US6800452B1 (en) 1994-08-08 2004-10-05 Science Applications International Corporation Automated methods for simultaneously performing a plurality of signal-based assays
US6777236B1 (en) 1994-12-14 2004-08-17 Institut Pasteur Process for producing a neuronal host cell in vitro comprising regulatory sequences of the β2-subunit of the neuronal nicotinic acetylcholine receptor
US6177242B1 (en) * 1994-12-14 2001-01-23 Institut Pasteur Genomic DNA fragments containing regulatory and coding sequences for the β2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments
US6485967B1 (en) 1995-06-07 2002-11-26 Merck & Co., Inc. Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid
US5691365A (en) * 1995-07-18 1997-11-25 University Of Kentucky Research Foundation Nicotinic receptor antagonists in the treatment of neuropharmacological disorders
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles
US6528630B1 (en) 1997-12-03 2003-03-04 Merck & Co., Inc. Calcium channel compositions and methods
US6632823B1 (en) 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
DE19850429A1 (de) * 1998-10-27 2000-05-04 Andre Schrattenholz Fragmente
JP2005506056A (ja) * 2001-06-06 2005-03-03 ニューロサーチ、アクティーゼルスカブ カチオン伝導gabaaレセプターおよびその使用
US7700749B2 (en) 2001-08-31 2010-04-20 Agensys, Inc. Nucleic acid and corresponding protein entitled 205P1B5 useful in treatment and detection of cancer
HUP0501017A3 (en) * 2001-12-14 2010-06-28 Targacept Methods and compositions for treatment of central nervous system disorders
WO2005030145A2 (en) * 2003-09-24 2005-04-07 Targacept, Inc. Composition and pharmacology of novel alpha-6-containing nicotinic acetylcholine receptors
US7879913B2 (en) * 2005-06-28 2011-02-01 Catholic Healthcare West Iptakalim hydrochloride for decreasing nicotine use
US20070218456A1 (en) * 2006-02-08 2007-09-20 Invitrogen Corporation Cellular assays for signaling receptors
CA2777843A1 (en) 2009-10-16 2011-04-21 University Of South Florida Treatment of suicidal ideation or behavior using inhibitors of nicotinic acetylcholine receptors
WO2012050646A2 (en) 2010-06-29 2012-04-19 The Trustees Of The University Of Pennsylvania Biomimetic chemical sensors using nanoelectronic readout of olfactory receptors
US10983117B2 (en) 2011-08-31 2021-04-20 The Trustees Of The University Of Pennsylvania Carbon nanotube biosensors and related methods
US11415546B2 (en) 2014-09-05 2022-08-16 The Trustees Of The University Of Pennsylvania Volatile organic compound-based diagnostic systems and methods

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518527A (en) * 1983-08-16 1985-05-21 Mitsubishi Chemical Industries Limited Polypeptides related to the pre-acetylcholine receptor-α of the electric organ of Torpedo californica
US4855231A (en) * 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4837148A (en) * 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
US4882279A (en) * 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US5024939A (en) * 1987-07-09 1991-06-18 Genentech, Inc. Transient expression system for producing recombinant protein
US4929555A (en) * 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US5386025A (en) * 1990-02-20 1995-01-31 The Salk Institute Biotechnology/Industrial Associates Calcium channel compositions and methods
EP0424397B1 (en) * 1988-04-04 1996-06-19 The Salk Institute Biotechnology Industrial Associates, Inc. Calcium channel compositions and methods
DK0463064T3 (da) * 1989-03-14 1999-11-29 Salk Inst For Biological Studi Neuronale nicotinacethylcholinreceptorsammensætninger indeholdende beta-4-underenheden
EP0497894A4 (en) * 1989-10-25 1993-03-31 The Salk Institute For Biological Studies Receptor infection assay
US5091518A (en) * 1989-11-16 1992-02-25 The Salk Institute For Biological Studies Beta retinoic acid response elements compositions and assays
US5369028A (en) * 1990-04-03 1994-11-29 The Salk Institute Biotechnology/Industrial Associates, Inc. DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
WO1995013299A1 (en) * 1993-11-08 1995-05-18 The Salk Institute Biotechnology/Industrial Associates, Inc. Human neuronal nicotinic acetylcholine receptor compositions and methods employing same

Also Published As

Publication number Publication date
CA2078572C (en) 2001-05-22
EP0523187A1 (en) 1993-01-20
DE69133135D1 (de) 2002-11-21
US5981193A (en) 1999-11-09
DE69133135T2 (de) 2003-06-18
US5369028A (en) 1994-11-29
EP0523187B1 (en) 2002-10-16
ATE226247T1 (de) 2002-11-15
WO1991015602A1 (en) 1991-10-17
CA2078572A1 (en) 1991-10-04
EP0523187A4 (es) 1994-04-06

Similar Documents

Publication Publication Date Title
ES2183801T3 (es) Composiciones del receptor de acetilcolina nicotinico neuronal humano y procedimientos que lo usan.
Nobuo et al. Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay
ES2057571T3 (es) Receptor de pdgf-alfa.
ATE449076T1 (de) Imidazolderivate als histamin-h3-modulatoren
PE20001225A1 (es) Derivados de adenina
PT1053256E (pt) Anticorpos para o receptor de morte 4 (dr4) e utilizações destes
PT813525E (pt) Derivados de benzamidina e sua utilizacao como anticoagulantes
ES2195163T3 (es) Derivados de pirimidina biciclicos y su uso como anticoagulantes.
BR0113980A (pt) Compostos de succinimida heterocìclicos fundidos e seus análogos, moduladores de função de receptor de hormÈnio nuclear
DK1135153T3 (da) Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser
BG99885A (en) Pyrene-pyridine derivatives
YU83600A (sh) Adenozin a3 receptorski modulatori
NO20010446L (no) Substituert anilidforbindelser og metoder
BRPI0415361A (pt) antagonistas do receptor muscarìnico de acetilcolina
BG99605A (bg) Антагонисти на растежния фактор на ендотелните клетки на кръвоносната система
NO960630L (no) Heterocykler anvendelige som neurokinin antagonister
DK0888385T3 (da) GDNF receptor og anvendelser deraf
WO2004058717A8 (en) Isoquinolinone derivatives and their use as therapeutic agents
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
MX9203401A (es) Anticuerpos antagonistas de la interleukina-4 humana.
DK1181319T3 (da) Kimære DR4-antistoffer og anvendelser deraf
WO1998018430A3 (en) P2y receptor antagonists
BRPI0412537A (pt) antagonista do receptor muscarìnico da acetilcolina
PT869955E (pt) As n-acil-2-substituidas-4-(substituidas com residuos benzimidazolilo ou imidapiridinilo)-piperidinas como antagonistas das taquicininas
ATE312915T1 (de) Neurturin-rezeptor